• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SGQ
Click for more information
5.71% 3.3¢

ST GEORGE MINING LIMITED - Charts / Financials

Market Cap $35.92M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

St George Mining Limited is a mining exploration company focused on creating shareholder... St George Mining Limited is a mining exploration company focused on creating shareholder value through the discovery of world class deposits. At its flagship Mt Alexander Project in Western Australia, St George boasts Australia’s latest nickel-copper sulphide discovery. High-grade nickel-copper-sulphide-PGE mineralisation occurs from just 30m below surface and over a 4.5km strike of the Cathedrals Belt.More

refresh Created with Sketch. REFRESH
Last update - 12.02pm 02/10/2024 (20 minute delay) ?
Day
Open 3.5¢   Day High 3.5¢   Day Low 3.3¢
Daily Volume 2881031
Bids   Sellers
Number Price Volume   Number Price Volume
4 3.2¢ 3890354   3 3.3¢ 49955

Directors & Senior Management

Mr. John Prineas Executive Chairman of the Board
Mr. John Prineas Executive Chairman of the Board
Mr. John Dawson Non-Executive Director
Ms. Sarah Shipway Non-Executive Director, Company Secretary

Data source: Refinitiv

(20min delay)
Last
3.3¢ 		Change
-0.002(5.71%) 		Mkt cap ! $35.92M
Open High Low Value Volume
3.5¢ 3.5¢ 3.3¢ $95.25K 2.881M

Buyers (Bids)

No. Vol. Price($)
4 3890354 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 49955 3
View Market Depth
Last trade - 12.08pm 02/10/2024 (20 minute delay) ?
Last
3.3¢ 		  Change
-0.002 ( 0.00 %)
Open High Low Volume
3.3¢ 3.3¢ 3.2¢ 3660696
Last updated 12.02pm 02/10/2024 ?

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.